Please Note: Due to volume considerations, not all questions can be answered. Questions most likely to be answered will be those of general interest to a broad group of visitors to this forum. Questions pertaining to a specific case; requests for diagnosis, medical advice, or second opinion; or requests for opinions about untested alternative therapies will generally not be answered.
The participation of Dr. Renslow Sherer in this
Forum is made possible in part by an unrestricted educational grant
from Abbott Laboratories.
|
|
 |
|
mutations treatment naive
May 7, 2007
Dr. Sherer
I know I really shouldnt' be using this forum to ask questions as I'm treatment naive but infected with a virus from someone who likely was treatment experienced.
Not on meds, numbers are currently just "ok", soon may need to be. VL's below 6000 and CD4 311-500 curently 351, %'s 30-40
No co morbid pathology. Mid 50's
infected since 2004.
These are the mutations
RT: K20R, M41L, K101Q, Q102K, K122E,I135R, C162S, Y181C, Q207E, R212R/K, T215D, H221H/Y, K223K/R, V245K, R227K, L281I, L238I, R284K
PR: T12P, R41K, Q61E, I64V, C67Y, H69Y, I72V
RC 21%
When the time comes, what ART regimen would you suggest.
Thanks
|
 |
|
 |
|
Response from Dr. Sherer
This is an important question. I suggest that you take my suggestions to your next doctor's appointment to talk through them. There may be other issues that I am not aware of that would influence your choice of initial therapy, e.g. other medications you are on, other conditions, etc.
Most of the mutations are polymorphisms with relatively little impact, but, as you suggest, there are some important mutations to take into account, as follows:
NRTI: 41, 181, 215
PR: 67, 72
I would recommend that you and your doctor get a phenotype test to complement this genotype, as you may learn a little more about the actual responses of the nucleoside drugs and the PIs to your virus.
In any event, you have the Y181C, which means that efavirenz and nevirapine are unlikely to be active. I would avoid the NNRTI class for now, although there are second generation drugs that may be useful in future.
Thus we are talking about a protease inhibitor for intial therapy, and there the most common choices are lopinavir, atazanavir, and fox-amprenavir, all of which can be used once daily.
You also have some nucleoside mutations, but you should be able to get the full benefit from Truvada, which is co-formulated tenofovir and emtricitabine, which would be my first recommendation.
Together, these choices would mean four or five pills once daily, with a good expection of a durable response and minimal side effects.
As above, I suggest you talk to your doctor about these suggestions.
|
|
|
 Please remember that this forum is designed for educational purposes only, and experts are not engaged through this
forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible
for editing and fact-checking their material. Neither The Body nor any sponsor is the publisher or speaker of posted visitors' questions or the experts' material.
Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body, Body Health Resources Corporation or any sponsor of this
forum. While neither The Body nor Body Health Resources Corporation regularly reviews posted content, we reserve the right to delete, move, or
edit postings if we deem it appropriate under the circumstances. Visitors submitting questions remain solely responsible for the content of their
messages.
Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as
legal or other professional advice. This information is not a substitute for professional advice or care. If you have or suspect you may have a
health or legal problem, you should consult your own health care provider or your attorney.
Copyright notice.
|
|
|
|
